Overview of Older People, Ageing and Diabetes, the Disease

  • Trisha DunningEmail author


  • Older people are individuals: they are not defined by their age or their diabetes.

  • Ageing is unique to every individual. Chronological age is not a good indicator of health status or care needs.

  • Health status in older age is influenced by genetics and lifestyle behaviours in younger age.

  • Increasing age is a risk factor for diabetes. Most older people have type 2 diabetes but people with type 1 diabetes survive to older age and type 1 can be first diagnosed in older age.

  • It is essential to personalise care with the individual and to use a proactive, risk identification and minimise approach.


  1. Abdelhafz A, Rodrigeuz-Manas L, Morley J, Sinclair A (2015) Hypoglycaemia in older people- a less well recognised risk factor for frailty. Ageing Dis 6:156–167CrossRefGoogle Scholar
  2. American Geriatric Society (2015) Identifying medicines that should be avoided in older people or used with caution. Updated BEERs criteria.
  3. Anderson P (2014) Managing diabetes in nursing and care homes. Nurs Times 110(34/35):20–22PubMedGoogle Scholar
  4. Anderson M, Powell J, Campbell K et al (2014) Optimal management of type 2 diabetes in patients at increased risk of hypoglycaemia. Diabetes Metab Syndr Obes 7:85–94PubMedPubMedCentralGoogle Scholar
  5. Ari Y, Martin-Ruiz C, Takayama M et al (2015) Inflammation, but not telomere length predicts successful ageing at extreme old age: a longitudinal study of semi-supercentenarians. EBioMedicine 2:1549–1558CrossRefGoogle Scholar
  6. Australian Centre for Social Innovation (tasci) (2016)Google Scholar
  7. Australian Medicines Handbook (2017)
  8. Brown M, Aggleton J (2001) Recognition memory: what are the roles of the perirhinal cortex and hippocampus? Nat Rev Neurosci 2:51–61PubMedCrossRefGoogle Scholar
  9. Brown R, Diaz-Ramirez Z, Boscardin W et al (2017) Functional impairment in middle age: a cohort study. Ann Intern Med.
  10. Butler R (1969) Age-ism: another form of bigotry. The Gerontologist 9(4, Part 1):243–246PubMedCrossRefGoogle Scholar
  11. Butler R (1980) Ageism: a foreword. J Soc Issues 36(2):8–11CrossRefGoogle Scholar
  12. Callahan M (2015) Searching for Grace Kelly. Mariner Books, New YorkGoogle Scholar
  13. Carey M, Shah S, DeWilde S et al (2014) Increased risk of acute cardiovascular events after partner bereavement. JAMA Intern Med.
  14. Cheung N, Chipps R (2010) Sliding scale insulin: will the false idol finally fall? Intern Med J 40:662–664PubMedCrossRefGoogle Scholar
  15. Chopra S, Kewal A (2012) Does hypoglycaemia cause hypoglycaemic events? Indian J Endocrinol Metab 10(1):102–104CrossRefGoogle Scholar
  16. Cox D, Goner-Frederick L, Polonsky W et al (2001) Blood Glucose Awareness training (BGAT-2). Diabetes Care 24(4):637–642PubMedCrossRefGoogle Scholar
  17. Crist C (2017) ‘Caregiver burden’ affects people with sick pets too. http://bit.ly2wRYidw
  18. Cryer P (2007) Hypoglycaemia, functional brain failure and brain death. J Clin Investig 117(4):866–870CrossRefGoogle Scholar
  19. Debrabant B, Sorensen M, Flachsbart F et al (2014) Human longevity and variation in DNA damage response and repair: a study of the contribution of sub-processes using competitive gene-set analysis. Eur J Hum Genet 22(9):1131–1136PubMedPubMedCentralCrossRefGoogle Scholar
  20. Diabetes Australia (2011) A new language for diabetes: position statement. Scholar
  21. Dickinson J, Guzman S, Marynuik M et al (2017) The use of language in diabetes care and education. Diabetes Care 40(12):1790–1799PubMedCrossRefGoogle Scholar
  22. Do-Yeon K, Chang-O K, Hyunjung L (2016) Quality of diet and level of physical performance related to inflammatory markers in community-dwelling frail elderly people. J Nutr.
  23. Dunning T (2016) Assessing older people with diabetes in Australia. Diabetes Prim Care Aust 1(4):1–6Google Scholar
  24. Dunning T (2017) Ancient wisdom, modern science—do the twain meet? World Diabetes Day Professorial Lecture, Geelong, VICGoogle Scholar
  25. Dunning T, Cukier K (2014) HbA1c: chasing numbers or considering context? J Diabetes Nurs 18(1):13–18Google Scholar
  26. Dunning T, Sinclair S (2014) Glucose lowering medicines and older people with diabetes: the importance of comprehensive assessments and pharmacovigilance. Nurs Care 3(3).
  27. Dunning T, Savage S, Duggn N (2010) Guidelines for managing diabetes at the end of life.
  28. Dunning T, Savage S, Duggan N. (2013) The McKellar guidelines for managing older people with diabetes in residential and other care settings.
  29. Dunning T, Speight J, Bennett C (2017) Language, the ‘diabetes restricted cade/dialect’ and what it means for people with diabetes and clinicians. Diabetes Educ 43(1):18–26PubMedCrossRefGoogle Scholar
  30. Family Caregiver Alliance (2010) Caregiver health: a population at risk. Accessed June 2016
  31. Fiatarone Singh M (2010) Exercise comes of age as medicine for older adults. Res Dig 10(3):1–13Google Scholar
  32. Foster S (2017) High-risk foot and the effect of deteriorating reneal function and dialysis in people with diabetes. J Diabetes Nurs 21(1):10–18Google Scholar
  33. Frick D, Agostini I, Inouye S (2002) Delirium superimposed on dementia: a systematic review. J Am Geriatr Soc 124:165–183Google Scholar
  34. Genova L (2009) Still Alice. Simon & Schuster, LondonGoogle Scholar
  35. Graveling A, Deary I, Frier B (2013) Acute hypoglycaemia impairs executive cognitive function in adults with and without type 1 diabetes. Diabetes Care 36(10):3240–3246. PubMedPubMedCentralCrossRefGoogle Scholar
  36. Hambling C, Seidu S, Davies MJ et al (2016) Older people with type 2 diabetes, including those with chronic kidney disease or dementia, are commonly overtreated with sulfonylurea or insulin therapies. Diabet Med.
  37. Heald A, Anderson S, Cortes G, et al (2017) Hypoglycaemia in the over 75s: understanding the predisposing factors in type 2 diabetes (T2DM). Prim Care Diabetes.
  38. Herman R, Williams K (2009) Elderspeak’s influence on resistiveness to care: focus on behavioural events. Am J Alzheimer’s Dis Other Demen 24(5):417–423CrossRefGoogle Scholar
  39. Herzfeld D, Vaswami P, Marko M, Shadmehr R (2014) A memory of errors in semsorimotor learning. Science 345(6203):1349–1353PubMedPubMedCentralCrossRefGoogle Scholar
  40. Hope S, Taylor P, Shields B, et al (2017) Are we missing hypoglycaemia? Elderly patients with insulin-treated diabetes present to primary care frequently with non-specific symptoms associated with hypoglycaemia. Prim Care Diabetes.
  41. Horvath S (2013) DNA methylation age of human tissues and cell types. Genome Biol 14(10):R115PubMedPubMedCentralCrossRefGoogle Scholar
  42. Hubbard B, Sinclair D (2014) Small molecule SIRT1 activators for the treatment of ageing and age related diseases. Trends Pharmacol Sci 25(3):146–154CrossRefGoogle Scholar
  43. Ibrahim J, Bugeja L, Willoughby M, Bevan M, Kipsaina C, Young C, Pham T, Ranson D (2017) Premature deaths of nursing home residents: an epidemiological analysis. Med J Aust.
  44. IDF (2014) Language philosophy technical document and recommendations for communicating with and about people with diabetes
  45. International Diabetes Federation (IDF) (2013) Global guidelines for managing older people with type 2 diabetes.
  46. International Federation on Ageing (IFA) (undated) Measuring the benefits: companion animals and the health of older persons.
  47. Jang H (2016) Society, family and diabetes and older adults. Diabetes Metab 40:182–189CrossRefGoogle Scholar
  48. Jenkinson C, McGee H (1998)Health status measurement Radcliffe Medical Press, OxfordGoogle Scholar
  49. Jumnila R, List E, Berryman D et al (2013) The GH/IGF-1 axis in ageing and longevity. Nat Rev Endocrinol 9(6):366–376CrossRefGoogle Scholar
  50. Karlsson F, Tremaroli V, Nookaew L (2013) Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 489:99–103CrossRefGoogle Scholar
  51. Kenny C (2013) When hypoglycaemia is not obvious: diagnosing and treating under-recognised and undisclosed hypoglycaemia. Prim Care Diabetes.
  52. King K, Peacock J, Donnelly R (1999) The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol 48(5):643–646PubMedPubMedCentralCrossRefGoogle Scholar
  53. Kirkman S, Briscoe V, Clark N et al (2012) Diabetes in older adults. Diabetes Care 35:2650–2664PubMedPubMedCentralCrossRefGoogle Scholar
  54. Kitzelman K (2016) How does carer wellbeing relate to perceived quality of life in patients with cancer? J Clin Oncol.
  55. Kovalchev B, Cobelli C (2016) Glucose variability: timing. Risk, analysis and relationship to hypoglycaemia in diabetes. Diabetes Care 39:502–510CrossRefGoogle Scholar
  56. Kuramoto A (2006) Therapeutic benefits of tai chi exercise: research review. Wis Med J 105(7):42–46Google Scholar
  57. Langa K, Vijans S, Hayward R et al (2002) Informal caregiving for diabetes and non-diabetic compilations among elderly Americans. J Gerontol Psychiatry Sci 57:S177–S186CrossRefGoogle Scholar
  58. Lansky D (1998) Measuring what matters to the public. Health Aff 17(4):40–41CrossRefGoogle Scholar
  59. Launer L, Miller M, Williamson J et al (2011) Effects of randomisation to intensive glucose lowering on brain structure and function in type 2 diabetes ACCORD Memory in Diabetes Study. Lancet Neurol 10(11):969–977PubMedPubMedCentralCrossRefGoogle Scholar
  60. Lipska K, Krumholtz H (2017) Is haemoglobin A1c the right outcome for studies of diabetes? J Am Med Assoc.
  61. Lopez-Otin C, Partridge L, Serrano M, Kromer G (2013) Hallmarkes of ageing. Cell 153:1194–1216PubMedPubMedCentralCrossRefGoogle Scholar
  62. Mc Fadden S, Thibault J (2001) Chronos to Kairos Christian perspectives in time and ageing. In: McFadden S, Atchley R (eds) Aging and the meaning of time. Springer Publishing Company, New York, pp 229–250Google Scholar
  63. McCall A (1992) The impact of diabetes on the CNS. Diabetes 41(5):557–570PubMedCrossRefGoogle Scholar
  64. McCoy R, Lopska K, Yao X et al (2016) Intensive treatment and severe hypoglycaemia among adults with type 2 diabetes. J Am Med Assoc Intern Med 176:969–978Google Scholar
  65. McGovern A, Hine J, de Lausignan S (2016) Infection risk in elderly people with reduced glycaemic control. Lancet Diab Endocrinol 4:303–304CrossRefGoogle Scholar
  66. Meneilly G. (2011) Diabetes in the elderly. Canadian Journal Diabetes, June 13–14Google Scholar
  67. Mostofsky E, Maclure M,Sherwood J (2012) Risk of acute myocardial infarction after death of a significant person in one’s life: the determinant of MI study. Circulation.
  68. Munshi M, Florez H, Huang E et al (2016) Management of diabetes in long-term care and skilled nursing facilities: a position statement of the American Diabetes Association. Diabetes Care 39(2):308–318PubMedPubMedCentralCrossRefGoogle Scholar
  69. Nathan D and for the DCCT/EDIC Research Group (2014) The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care 37(1):9–16. CrossRefGoogle Scholar
  70. National Ageing Research Institute (NARI) (2017) The New Middle Age: ways to thrive in the longevity economyGoogle Scholar
  71. National Institute of Clinical Excellence (2002) (NICE) (2015) Diabetes in Adults: management (NG28) NICE London. Accessed June 2017
  72. Nelson P, Carnegie P, Martin J et al (2003) Demystified human endogenous retroviruses. J Clin Pathol 56(1):11–16CrossRefGoogle Scholar
  73. Ogurtsova K, da Rocha FJ, Huang Y et al (2017) IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015–2040. Diabetes Res Clin Pract 128:40–50PubMedCrossRefGoogle Scholar
  74. Passarino G, De Ranao F, Montesantto A (2016) Human longevity: genetics or Lifestyle? It takes two to tango. Immun Ageing.
  75. Peters K, Davis W, Ito J et al (2017) Identification of novel circulating biomarkers predicting rapid decline in renal function in type 2 diabetes: the fremantle diabetes study phase II. Diabetes Care 40(11):1548–1555PubMedCrossRefGoogle Scholar
  76. Petersen K, Dufour S, Befroy D et al (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350:664–671PubMedPubMedCentralCrossRefGoogle Scholar
  77. Raule N, Sevini F, Li S et al (2016) The co-occurrence of mDNA mutations on different oxidative phosphorylation subunits not detected by haplogroup analysis affects human longevity and is population specific. Ageing Cell 13(3):401–407CrossRefGoogle Scholar
  78. Richeson J, Shelton N (2006) A social psychological perspective on stigmatisation of older adults National Library of Medicine.
  79. Rizzo M, Marfella R, Barberi M et al (2010) Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients. Diabetes Care 33(10):2169–2174PubMedPubMedCentralCrossRefGoogle Scholar
  80. Rockwood K, Song A, MacKnight C et al (2005) A global clinical measure of fitness and frailty in elderly people. Can Med Assoc J 173:489–495CrossRefGoogle Scholar
  81. Ryan C, Geckle M (2000) Why is learning and memory dysfunction in type 2 diabetes limited to older adults? Diabetes Metab Res Rev 16(5):308–315PubMedCrossRefGoogle Scholar
  82. Satz P (1993) Brain reserve capacity on symptom onset after brain injury: a formulation and review of evidence for threshold theory. Neuropsychology 7:273–295CrossRefGoogle Scholar
  83. Scarletti J, Schwartz M (2015) Gut-brain mechanisms controlling glucose homeostasis. F1000Prime Rep 7:12. CrossRefGoogle Scholar
  84. Schachter F, Faure-Deland L, Geunot F et al (1994) Genetic associations with human longevity at APOE and ACE Loci. Nat Genet 6(1):29–32PubMedCrossRefGoogle Scholar
  85. Scott D, deCourten B, Ebeling P (2016) Sarcopaenia: a potential cause and consequence of type 2 diabetes in Australian. Med J Aust 205(7):329–333PubMedCrossRefGoogle Scholar
  86. Siafarikas A, Johnston R, Bulsara M et al (2012) Early loss of the glucagon response to hypoglycemia in adolescents with type 1 diabetes. Diabetes Care 35(8):1757–1762. PubMedPubMedCentralCrossRefGoogle Scholar
  87. Sinclair A, Gadsby R, Penfold S, Croxson S, Bayer A (2001) Prevalence of diabetes in care home residents. Diabetes Care 24(6):1066–1068PubMedCrossRefGoogle Scholar
  88. Sinclair A, Dunning T, Rodrigeuz-Manas L (2014) Diabetes in older people: new insights and remaining challenges. Lancet Diab Endocrinol.
  89. Sinclair A, Abdelhafiz A, Rodrigeuz-Manas L (2017) Frailty and sarcopenianewly emerging and high impact complications of diabetes. J Diabetes Complicat 31:1465–1473PubMedCrossRefGoogle Scholar
  90. Sorensen M, Thinggaard M, Nygaard M et al (2012) Genetic variation in TERT and TERC and human leucocyte telomere length and longevity: a cross-sectional and longitudinal analysis. Ageing Cell 11(2):223–227CrossRefGoogle Scholar
  91. Squire L, van der Horst A, McDuff S et al (2010) Role of the hippocampus in remembering the past and imagining the future. Proc Natl Acad Sci U S A 107(44):19044–19048. PubMedPubMedCentralCrossRefGoogle Scholar
  92. Stern Y (2001) What is cognitive reserves? Theory and research application of the reserve concept. J Int Neuropsychol Soc 8:448–460CrossRefGoogle Scholar
  93. Sun X, Walker N, Wagner M, Bachman D (2012) APOE genotype in the diagnosis of Alzheimer’s disease in patients with cognitive impairment. J Alzheimer’s Dis Other Demen 27(5):15–20Google Scholar
  94. Swerissen H, Duckett, S (2014) Dying well. Grattan Institute. ISBN: 978-1-925015-61-4.
  95. The Diabetes Control and Complications Trial (DCCT) Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986. PMID: 8366922CrossRefGoogle Scholar
  96. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R, UKPDS 25 (1997) Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet 350:1288–1293PubMedCrossRefGoogle Scholar
  97. United Kingdom Prospective Diabetes Study (UKPDS) Prospective Diabetes Study Group (1998) Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. UKPDS 33. Lancet 352:837–853CrossRefGoogle Scholar
  98. Wagner W (2017) Epgenetics, ageing clocks in mice and men. Genome Biol 18:107. PubMedPubMedCentralCrossRefGoogle Scholar
  99. Wei L, Fearing M, Sternberg E, Inouye S (2008) The Confusion Assessment Method (CAM): a systematic review of current usage. J Am Geriatr Soc 56(5):823–830. doi: Accessed April 2017
  100. Weng S, Landes S (2017) Culture and language discordance in the workplace: evidence form the national home aide health survey. The Gerontologist 57(5):900–909PubMedGoogle Scholar
  101. World Health Organisation (WHO) (2002) Proposed working definition of an older person in Africa for the MDS Project. Accessed April 2017Google Scholar
  102. WHO (2017) definition of palliative care WHO.
  103. Worldwide Palliative Care Alliance (WPCA)/World Health Organisation (WHO) (2014) Accessed April 2017
  104. Yaffe C, Fulvey C, Hamilton M (2013) Association between hypoglycaemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med 173(14):1300–1306PubMedPubMedCentralCrossRefGoogle Scholar
  105. Yaffe K, Vittinghoff E, Pletcher M et al (2014) Early adult to midlife cardiovascular risk and cognitive decline. Circulation 129(15):1560–1567PubMedPubMedCentralCrossRefGoogle Scholar
  106. Zanh J, Kaplan M, Fischer S et al (2015) Expansion of a novel endogenous retrovirus throughout the pericentromeres of modern humans. Genome Biol 16(1):74–92CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Centre for Quality and Patient Safety Research, Barwon Health PartnershipDeakin UniversityGeelongAustralia

Personalised recommendations